Page 186 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Liver Tumours: Management (Cont.)

P0381 CLINICAL IMPACT OF ACHIEVING SUSTAINED
VIROLOGICAL RESPONSE IN HEPATITIS C
VIRUS -INFECTED PATIENTS WITH EARLY STAGE
HEPATOCELLULAR CARCINOMA
Kaoru Tsuchiya*,Yu Asano, Nobuharu Tamaki,Yutaka Yasui,
Shoko Suzuki, Takanori Hosokawa, Hiroyuki Nakanishi, Jun Itakura,
Masayuki Kurosaki, Namiki Izumi, Japan

YI P0382 ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONISTS AS
ADJUVANT THERAPY FOR HEPATOCELLULAR CARCINOMA
PATIENTS TREATED WITH RADIOFREQUENCY ABLATION
Antonio Facciorusso*, Valentina Del Prete, Nicola Crucinio,
Alfredo Di Leo, Michele Barone, Italy

YI P0383 COMBINED SEQUENTIAL USE OF HAP AND ART SCORES
TO PREDICT TRANSARTERIAL CHEMOEMBOLIZATION
ePOSTERS FAILURE IN HEPATOCELLULAR CARCINOMA: A MULTI-
CENTER COMPARATIVE STUDY
David James Pinato*, Tadaaki Arizumi, Jeong W. Jang, Elias Allara,
Puvan Suppiah, Carlo Smirne, Glenda Grossi, Mario Pirisi,
Masatoshi Kudo, Rohini Sharma, The United Kingdom

YI P0384 ASSESSMENT OF TREATMENT RESPONSE BY
SEQUENTIAL SERUM METABOLOMIC PROFILING AFTER
PERCUTANEOUS RADIOFREQUENCY ABLATION OF
HEPATOCELLULAR CARCINOMA
Corentine Goossens*, Pierre Nahon, Laurence Le Moyec,
Mohamed N. Triba, Nadia Bouchemal, Roland Amathieu,
Nathalie Ganne-Carrié, Marianne Ziol, Jean-Claude Trinchet,
Abou Diallo, Olivier Seror, Philippe Savarin, France

YI P0385 PROGNOSTIC IMPACT OF THE BAVENO IV STAGING
SYSTEM OF PORTAL HYPERTENSION IN PATIENTS WITH
CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
Florian Hucke*, Eva Pachta, Thomas Reiberger, Mattias Mandorfer,
Wolfgang Sieghart, Markus Peck-Radosavjlevic, Austria

YI P0386 PREDICTING LIVER DECOMPENSATION AFTER
RESECTION FOR HEPATOCELLULAR CARCINOMA: A
RECURSIVE PARTITIONING ANALYSIS OF PROGNOSTIC
FACTORS
Davide Citterio*, Carlo Sposito, Antonio Facciorusso,
Maria Flores Reyes, Michele Mazzola, Vincenzo Mazzaferro, Italy

186 The International Liver Congress™ 2015 • ILC Programme